Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31485 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Naoki Yoshioka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan. Hauptthemen laut MEDLINE: Popliteal Artery, Femoral Artery, Peripheral Arterial Disease, Coated Materials, Biocompatible. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Previous studies have shown comparable outcomes between first‐generation high‐dose drug‐coated balloon (HD‐DCB) and second‐generation low‐dose drug‐coated balloon (LD‐DCB) for femoropopliteal artery disease. However, data about the clinical performances of these DCBs for longer lesions in real‐world clinical settings are limited.
Methods
In this multicenter, retrospective study, the clinical performances of the HD‐DCB (IN.PACT, Medtronic, MN, USA) and the LD‐DCB (Ranger, Boston, MA, USA) were assessed in cases of femoropopliteal artery disease with lesion length ≥ 150 mm. From the database, 288 lesions in 288 patients were assigned to the HD‐DCB group, and 88 lesions in 88 patients were assigned to the LD‐DCB group. Propensity score‐matching analysis was performed to adjust for baseline patient and lesion characteristics. The primary outcome was the 2‐year primary patency rate of the two types of DCBs.
Results
Propensity score matching was used to extract 76 pairs with no significant intergroup differences in baseline patient and lesion characteristics. The average lesion length was 257.5 and 255.7 mm in the HD and LD‐DCB groups, respectively. The 2‐year primary patency rates between the HD and LD‐DCB groups were comparable (68.5% vs. 60.4%; p = 0.33). There were also no significant differences in clinically driven target lesion revascularization, acute limb ischemia, major amputation, or overall survival between the two types of DCBs.
Conclusion
The clinical outcomes between the HD and LD‐DCBs did not significantly differ in real‐world populations with severely complex lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
- Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
- Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
- Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
- Department of Cardiology, Saiseikai Yokohama City Eastern Hospital, Yokohama, Japan.
- Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan.
ORCID-Profile: Naoki Yoshioka, Takahiro Tokuda, Takashi Yanagiuchi, Kenji Ogata, Tatsuya Nakama
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Yoshioka, N., Tokuda, T., Tanaka, A., Kojima, S., Yamaguchi, K., Yanagiuchi, T., Ogata, K., Takei, T., Morita, Y., Nakama, T., Morishima, I., & LEADers PAD investigators (2025). Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31485
Vancouver
Yoshioka N, Tokuda T, Tanaka A, Kojima S, Yamaguchi K, Yanagiuchi T, et al. Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31485
BibTeX
@article{Yoshioka2025,
author = {Yoshioka, Naoki and Tokuda, Takahiro and Tanaka, Akiko and Kojima, Shunsuke and Yamaguchi, Kohei and Yanagiuchi, Takashi and Ogata, Kenji and Takei, Tatsuro and Morita, Yasuhiro and Nakama, Tatsuya and Morishima, Itsuro and LEADers PAD investigators, LEADers PAD investigators},
title = {Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31485}
}
EUVIMED